Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 15, Number 1—January 2009

Avian Influenza Virus (H5N1) in Human, Laos

Cite This Article

Appendix Figure

Thumbnail of Phylogenetic analysis of avian influenza viruses (H5N1). A) hemagglutinin genes and B) polymerase A genes. Pseudosampling = 1,000. Known genotype V viruses are indicated in red, and genotype Z viruses are indicated in blue. Numbers on the right in braces indicate clades and subclades. Scale bars indicate genetic distances between sequences of different taxa. HK, Hong Kong.

Appendix Figure. Phylogenetic analysis of avian influenza viruses (H5N1). A) hemagglutinin genes and B) polymerase A genes. Pseudosampling = 1,000. Known genotype V viruses are indicated in red, and genotype Z viruses are...

To the Editor: The first avian influenza (H5N1) outbreak in poultry in Laos occurred in 2003 and subsided in March 2004 after massive killing of poultry to contain the disease. Extensive surveillance from July 2005 through January 2006 did not detect any influenza virus subtypes in chicken, ducks, quails, and pigs in live bird markets in the Vientiane, Champasak, and Savannakhet Provinces (1). Avian influenza virus (H5N1) was reintroduced into Laos in February 2006 but showed a lower incidence. Viruses isolated in this country in 2004 belonged to genotype Z, clade 1, and 2006 isolates belonged to clade 2.3.4 (Appendix Figure, panel A, (1).

Avian influenza (H5N1) had not been reported in humans in Laos until February 27, 2007 (2). Our patient was a 15-year-old adolescent girl who lived in a suburb of Vientiane where an outbreak of influenza (H5N1) in poultry had been confirmed on February 7, 2007. Influenza-like symptoms developed in the patient on February 10. She was hospitalized in Vientiane with fever and respiratory symptoms on February 15. On February 17, her parents brought her to a private hospital in Nong Khai Province, Thailand. Oseltamivir was prescribed on February 19. On February 20, she was transferred to the Nong Khai Provincial Hospital because of rapid, progressive, severe pneumonia with acute respiratory distress syndrome. When we suspected avian influenza in this patient, clinical specimens were tested.

A diagnosis of infection with avian influenza (H5N1) was based on positive results obtained by reverse transcription–PCR (RT-PCR), viral isolation in MDCK cells inoculated with an endotracheal suction specimen collected on February 22, and a 4-fold increase in neutralizing antibody titers from 80 to 320 in paired blood specimens collected on February 25 and March 1, as assayed against autologous virus. This virus isolate was named A/Laos/Nong Khai 1/07(H5N1). Subsequent samples were collected on February 25 and March 7 (day of death). Results of RT-PCR were positive for the sample collected on February 25 only; virus isolation results were negative for both samples.

The virus was screened for a novel reassorted gene by a multiplex RT-PCR and 8 primer pairs specific for each genomic segment of genotype Z, clade 1 virus (3). All segments except the polymerase A (PA) segment were amplified, which indicated that the new virus was different from genotype Z viruses. The viral genome was sequenced and submitted to GenBank (accession nos. EU499372–EU499379 for hemagglutinin, nonstructural protein, matrix protein, nucleoprotein, PB1, PB2, neuraminidase, and PA genes, respectively). Phylogenetic analysis showed that this virus belonged to genotype V (Appendix Figure, panel B) (4); phylogenetic analysis of the hemagglutinin gene ( showed that it belonged to clade 2.3.4 (Appendix Figure, panel A).

Protein sequence at the hemagglutinin cleavage site harbored many basic amino acids (RERR_RKR). One amino acid deletion and 1 amino acid change were found when compared with RERRRKKR, which is present in most avian influenza viruses (H5N1). There was no change in receptor binding site. This virus had glutamic acid at aa 627 in the PB2 protein, aspartic acid at aa position 92 in nonstructural protein 1, and 5 aa deletions at positions 80–84 in the nonstructural protein 1. Analysis of the neuraminidase gene showed a 20-aa deletion in the stalk protein; there was no mutation of histidine to tyrosine at aa position 274, a position shown to be the oseltamivir resistance marker in the neuraminidase 1 viral genome (5). Mutations in the matrix 2 gene showed that amantadine resistance was not present in our virus (6). Our in vitro assay (7) showed that this virus was sensitive to oseltamivir and amantadine.

Since 2003, genotype V influenza viruses (H5N1) have been reported in some East Asian countries. Genetic diversity in the hemagglutinin gene has classified those genotype V viruses into distinct clades. Viruses from avian species in South Korea in 2003 and Japan in 2004 (8,9) belong to clade 2.5. A/chicken/Shanxi/2/2006 isolate belonged to clade 7. Human cases in People’s Republic of China, i.e., A/China/GD01/06, A/Shenzhen/406H/06, A/Jiangsu/1/2007, and A/Jiangsu/2/2007, belong to clade 2.3.4, the same clade as A/chicken/Thailand/NP-172/2006 and the virus from our study.

Highly pathogenic avian influenza viruses (H5N1) that caused outbreaks in Thailand since 2004 belong to genotype Z, clade 1. Introduction of genotype V clade 2.3.4 virus, A/chicken/Thailand/NP-172/2006, to Nakhon Phanom Province occurred in November 2006 (10), the same year that clade 2.3.4 virus was introduced into Laos (Appendix Figure, panel A). On the basis of hemagglutinin gene phylogeny, A/Laos/Nong Khai 1/2007 is closely related to A/chicken/Nong Khai/NIAH 400802/2007 and A/chicken/Thailand/NP-172/2006. Phylogenetic analysis suggested that viruses from these 2 countries shared the same origin. There was extensive movement across the Mekong River even before the bridge linking Nong Khai from Vientiane was opened. However, the route of transmission of genotype V viruses from east Asian to Southeast Asian countries could not be elucidated.



We thank the Lao Public Health Department, the Vientiane Municipal and Nong Khai Provincial Health Office, and Nong Khai Provincial Hospital for collaborative support of this study. The oseltamivir used in drug sensitivity assay was kindly provided by Roche, Ardenne, Belgium.

This study was supported by the National Biotechnology for Genetic Engineering, the Thailand Research Fund for Senior Research Scholar, and a Mahidol University research grant.


Pilaipan PuthavathanaComments to Author , Kantima Sangsiriwut, Achareeya Korkusol, Phisanu Pooruk, Prasert Auewarakul, Chakrarat Pittayawanganon, Derek Sutdan, Rungrueng Kitphati, Pathom Sawanpanyalert, Bounlay Phommasack, Khanthong Bounlu, and Kumnuan Ungchusak
Author affiliations: Mahidol University, Bangkok, Thailand (P. Puthavathana, K. Sangsiriwut, A. Korkusol, P. Pooruk, P. Auewarakul); Ministry of Public Health, Nonthaburi, Thailand (C. Pittayawanganon, D. Sutdan, R. Kitphati, P. Sawanpanyalert, K. Ungchusak); Ministry of Health, Vientiane, Laos (B. Phommasack, K. Bounlu)



  1. Boltz  DA, Douangngeun  B, Sinthasak  S, Phommachanh  P, Rolston  S, Chen  H, H5N1 influenza viruses in Lao People’s Democratic Republic. Emerg Infect Dis. 2006;12:15935.PubMedGoogle Scholar
  2. World Health Organization. First human case of avian influenza in the Lao People’s Democratic Republic. 2007 [cited 2008 Oct 6]. Available from
  3. Auewarakul  P, Sangsiriwut  K, Chaichoune  K, Thitithanyanont  A, Wiriyarat  W, Songserm  T, Surveillance for reassortant virus by multiplex reverse transcription-PCR specific for eight genomic segments of avian influenza A H5N1 viruses. J Clin Microbiol. 2007;45:16379. DOIPubMedGoogle Scholar
  4. Li  KS, Guan  Y, Wang  J, Smith  GJD, Xu  KM, Duan  L, Genesis of a highly pathogenic and potentially pandemic H5N1 influenza virus in eastern Asia. Nature. 2004;430:20913. DOIPubMedGoogle Scholar
  5. Wang  MZ, Tai  CY, Mendel  DB. Mechanism by which mutations at His274 alter sensitivity of influenza A virus N1 neuraminidase to oseltamivir carboxylate and zanamivir. Antimicrob Agents Chemother. 2002;46:380916. DOIPubMedGoogle Scholar
  6. Suzuki  H, Saito  R, Matsuda  H, Oshitani  H, Sato  M, Sato  I. Emergence of amantadine-resistant influenza A viruses: epidemiological study. J Infect Chemother. 2003;9:195200. DOIPubMedGoogle Scholar
  7. Puthavathana  P, Auewarakul  P, Charoenying  PC, Sangsiriwut  K, Pooruk  P, Boonnak  K, Molecular characterization of the complete genome of human influenza H5N1 virus isolates from Thailand. J Gen Virol. 2005;86:42333. DOIPubMedGoogle Scholar
  8. Mase  M, Tsukamoto  K, Imada  T, Imai  K, Tanimura  N, Nakamura  K, Characterization of H5N1 influenza A viruses isolated during the 2003–2004 influenza outbreaks in Japan. Virology. 2005;332:16776. DOIPubMedGoogle Scholar
  9. Mase  M, Kim  J-H, Lee  Y-J, Tsukamoto  K, Imada  T, Imai  K, Genetic comparison of H5N1 influenza A viruses isolated from chickens in Japan and Korea. Microbiol Immunol. 2005;49:8714.PubMedGoogle Scholar
  10. Chutinimitkul  S, Thaweesak  S, Amonsin  A, Payungporn  S, Suwannakarn  K, Damrongwatanapokin  S, New strain of influenza A virus (H5N1), Thailand. Emerg Infect Dis. 2007;13:5067.PubMedGoogle Scholar




Cite This Article

DOI: 10.3201/eid1501.080524

Related Links


Table of Contents – Volume 15, Number 1—January 2009

EID Search Options
presentation_01 Advanced Article Search – Search articles by author and/or keyword.
presentation_01 Articles by Country Search – Search articles by the topic country.
presentation_01 Article Type Search – Search articles by article type and issue.



Please use the form below to submit correspondence to the authors or contact them at the following address:

Pilaipan Puthavathana, Department of Microbiology, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok 10700, Thailand;

Send To

10000 character(s) remaining.


Page created: November 22, 2010
Page updated: November 22, 2010
Page reviewed: November 22, 2010
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.